Myopia Medical Services in China

Myopia, or nearsightedness, is a common refractive error in which distant objects appear blurry while close objects remain clear. It occurs when the eyeball is too long or the cornea’s curvature is too steep, causing light to focus in front of—not directly on—the retina. Prevalence is rising globally, especially among children and adolescents, with estimates suggesting over 30% of the world’s population affected—reaching up to 80–90% in some East Asian countries. While mild myopia can be corrected with glasses or contact lenses, progressive cases may lead to serious complications such as retinal detachment, glaucoma, or myopic maculopathy later in life. Early detection, lifestyle interventions (e.g., increased outdoor time), and evidence-based treatments—including orthokeratology (Ortho-K), low-dose atropine eye drops, and specialized multifocal contact lenses—are critical for slowing progression, particularly in pediatric patients. Surgical options like SMILE, LASIK, and ICL implantation are highly effective for stable adult myopia but require careful patient selection and thorough preoperative evaluation.

China offers distinct advantages for myopia management: world-class ophthalmic centers equipped with cutting-edge diagnostic tools (e.g., axial length biometry, wide-field retinal imaging), standardized national screening programs integrated into school health systems, and rapidly advancing research in myopia control—especially in pharmacologic and optical interventions. Chinese ophthalmologists have pioneered large-scale longitudinal studies demonstrating up to 60% reduction in annual axial elongation using combination therapies. Leading institutions such as Zhongshan Ophthalmic Center (Sun Yat-sen University) and Shanghai Eye & ENT Hospital report >95% patient satisfaction rates and publish regularly in top-tier journals including *Ophthalmology* and *JAMA Ophthalmology*.

China is a leading destination for myopia treatment, combining cutting-edge technology, extensive clinical expertise, and exceptional value. Chinese ophthalmic centers utilize state-of-the-art equipment—including top-tier femtosecond lasers, wavefront-guided diagnostic systems, and advanced SMILE and ICL implantation platforms—many approved by both NMPA and international regulators like CE and FDA. With over two decades of high-volume refractive surgery experience, Chinese surgeons perform tens of thousands of procedures annually, ensuring refined techniques and proven safety outcomes. Cost-effectiveness is another major advantage: premium laser vision correction or premium ICL surgery in China typically costs 40–60% less than in the US or Western Europe—without compromising quality, as all procedures follow strict national clinical guidelines and ISO-certified protocols. The patient journey is highly streamlined: online pre-consultations with bilingual ophthalmologists, rapid visa support (including medical invitation letters), coordinated airport transfers, multilingual medical coordinators, and seamless scheduling from diagnostics to surgery and follow-up—all within 3–5 days. Post-operative care includes remote monitoring and digital aftercare support. Combined with world-class hospitality and convenient access to major cities like Shanghai, Beijing, and Guangzhou, China offers a safe, efficient, and affordable solution for international patients seeking lasting myopia correction.

International patients seeking myopia correction begin with a free online consultation: submit medical records, refraction reports, and corneal topography (if available) via secure portal. Within 48 hours, an ophthalmologist reviews eligibility and recommends treatment options (e.g., SMILE, LASIK, or ICL). Upon acceptance, our dedicated International Patient Coordinator schedules the visit—typically within 2–4 weeks—and provides a personalized timeline. Patients must arrive 1–2 days pre-surgery for comprehensive diagnostics (corneal thickness, pupil size, dry eye assessment). Surgery is performed the next day under local anesthesia; most return home within 48 hours post-op. Follow-up is conducted remotely at Day 1, Week 1, and Month 1 via video consult. Required documents include passport, recent eye exam reports (≤6 months old), systemic health summary, and travel insurance. English-speaking coordinators assist throughout—from visa letter issuance and airport pickup to accommodation booking and real-time translation during consultations. All clinical staff are fluent in English; multilingual interpreters (Spanish, Arabic, Mandarin, Russian) are available on request. Total process duration: 5–7 days onsite. We offer 24/7 support, digital health records access, and post-treatment guidance in multiple languages.

For myopia treatment in China, international patients must obtain a valid Chinese visa—typically a tourist (L) or medical (Q2/S2) visa—before travel. Passport validity should exceed six months, and applicants may need an invitation letter from the chosen hospital. Upon arrival, all patients undergo basic health screening at entry points. Regarding insurance, most Chinese hospitals do not accept foreign health insurance directly; patients are advised to secure comprehensive international travel/medical insurance covering elective ophthalmic procedures and potential complications. Payment is typically made in advance via wire transfer, credit card (Visa/Mastercard), or Alipay/WeChat Pay (with foreign cards enabled). Accommodation options include hospital-affiliated guesthouses or nearby hotels with bilingual support; many clinics offer airport pickup and arrange local interpreters or patient coordinators for companionship during consultations and surgery. Post-treatment, patients receive personalized follow-up plans: remote consultations via video call, digital prescription renewals, and progress monitoring through secure platforms—all coordinated by dedicated international patient managers. Recommended post-op stay is 3–7 days for LASIK/SMILE procedures, depending on recovery and flight logistics. Always consult your home ophthalmologist before traveling and share pre-arrival eye exam reports with the Chinese clinic for pre-assessment.